A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer
Andrea Lunardi(Cancer Genetics (United States)), Ugo Ala(Cancer Genetics (United States)), Mirjam T. Epping(Beth Israel Deaconess Medical Center), Leonardo Salmena(Beth Israel Deaconess Medical Center), John G. Clohessy(Beth Israel Deaconess Medical Center), Kaitlyn A. Webster(Beth Israel Deaconess Medical Center), Guocan Wang(Cornell University), Roberta Mazzucchelli(Marche Polytechnic University), Maristella Bianconi(Marche Polytechnic University), Edward C. Stack(Harvard University), Rosina T. Lis(Dana-Farber Cancer Institute), Akash Patnaik(Beth Israel Deaconess Medical Center), Lewis C. Cantley(Harvard University), Glenn J. Bubley(Beth Israel Deaconess Medical Center), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), William L. Gerald(Memorial Sloan Kettering Cancer Center), Rodolfo Montironi(Marche Polytechnic University), Sabina Signoretti(Dana-Farber Cancer Institute), Massimo Loda(Dana-Farber Cancer Institute), Caterina Nardella(Memorial Sloan Kettering Cancer Center), Pier Paolo Pandolfi(Memorial Sloan Kettering Cancer Center)
Cited by 144Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis